Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment

Last updated: December 4, 2024
Sponsor: Acandis GmbH
Overall Status: Active - Recruiting

Phase

N/A

Condition

Aneurysm

Treatment

Accero® (heal) Stent

Clinical Study ID

NCT03957382
1041-1
  • All Genders

Study Summary

This study is intended to show that the application of the Accero® (heal) stent is safe within the given indication.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Any patient treated with ACCERO® (heal) Stent according to IFU and has signed the informed consent

Exclusion

Exclusion Criteria:

  • Patient is participating in another clinical trial

Study Design

Total Participants: 130
Treatment Group(s): 1
Primary Treatment: Accero® (heal) Stent
Phase:
Study Start date:
July 23, 2019
Estimated Completion Date:
December 31, 2026

Connect with a study center

  • Vivantes - Klinikum Neukölln Institut für klinische und interventionelle Neuroradiologie

    Berlin, 12351
    Germany

    Active - Recruiting

  • Universitätsklinikum Düsseldorf Institut für Diagnostische und Interventionelle Radiologie Abteilung Neuroradiologie

    Düsseldorf, 40225
    Germany

    Site Not Available

  • Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention, Universitätsklinikum Hamburg-Eppendorf

    Hamburg, 20246
    Germany

    Active - Recruiting

  • Otto-von-Guericke-Universität Magdeburg Universitätsklinik für Neuroradiologie

    Magdeburg, 39120
    Germany

    Site Not Available

  • Krankenhaus Ludmillenstift, Abteilung für Radiologie, Neuroradiologie und Nuklearmedizin

    Meppen, 49716
    Germany

    Active - Recruiting

  • KLINIKUM VEST GMBH Knappschaftskrankenhaus Klinik für Radiologie und Neuroradiologie

    Recklinghausen, 45657
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.